Vision_INM

The enthusiastic Kalatzis team @INM_Montpellier dedicated to research on inherited retinal disorders, from genetics to therapies for patients

[Elfride De Baere @elfridedebaere]

The new year has just begun and we already have novel RNU breakthroughs to share, this time in the eye genetics field:

De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa https://t.co/OYt1LRuUbu

[Vision_INM @Vision_INM]

I am proud to announce that we made the cover of the December issue of Molecular Therapy with an image of CRALBP expression in a human #retinal #organoid accompanying our published paper on #RLBP1. Congratulations H. Boukhaddaoiu for imaging and N. Erkilic for differentiation.

[Vision_INM @Vision_INM]

I am thrilled to announce that our latest article concerning #RLBP1, associated #IRD models, and #AAV-mediated gene replacement therapy is available online in Molecular Therapy. A big thank you to everyone involved.
https://t.co/vWm9paLTQb

[Vision_INM @Vision_INM]

Just finished a fantastic @iserworld meeting here in Buenos Aires, Argentina. Presented our work on #USH2A- and #RLBP1-associated IRDs. Heard a lot of exciting science. Congratulations to the organisers.

[Vision_INM @Vision_INM]

Nous recrutons un(e) IE pour travailler sur l’édition génomique des iPSC.
Pour plus de détails et afin de candidater, consulter :
https://t.co/uDXbi999Rc

[Vision_INM @Vision_INM]

Absolutely thrilled that our article on #USH2A retinal #organoids published in @HGGAdvances was hand-picked by the editors of @CellPressNews

[Vision_INM @Vision_INM]

@CellPressNews @HGGAdvances @INM_Montpellier @GeneticsSociety Absolutely thrilled that our paper on #USH2A retinal #organoids published in @HGGAdvances was hand-picked by the editors of @CellPressNews

[Cell Press @CellPressNews]

USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids
https://t.co/c1kvrLlyyZ
@HGGAdvances paper hand-picked by our editors
@Vision_INM @INM_Montpellier @GeneticsSociety

[Vision_INM @Vision_INM]

An enormous thank you to France Choroideremie and @curechm for their indispensable sponsorship. Happy 20th birthday France Choroideremie!

[Vision_INM @Vision_INM]

A big thank you to all the scientists that came to Montpellier to participate in our 4th International Choroideremia Symposium. A day of stimulating scientific presentations and discussions concerning #choroideremia.

[Vision_INM @Vision_INM]

We also thank the patient association representatives of France choroideremie @curechm @ProRetinaDe @fightforsightUK for their presence and contribution to the success of the meeting.

[Elfride De Baere @elfridedebaere]

Very much impressed by the professionalism, enthusiasm, knowledge and warm interactions of @curechm Big thank you Viki @Vision_INM and @INM_Montpellier colleagiues for the invitation, congrats on this top scientific and patient meeting 👌

[Vision_INM @Vision_INM]

We are happy to report that our latest article concerning #RLBP1, #IRDs and #gene therapy is available on BioRxiv. A collaboration with the @unil and @NIH.

[bioRxiv Molecular Biology @biorxiv_molbio]

Dual CRALBP isoforms unveiled: iPSC-derived retinal modelling and AAV2/5-RLBP1 gene transfer raise considerations for effective therapy https://t.co/EdXSuuHN72 #biorxiv_molbio

[Vision_INM @Vision_INM]

Correction to contact address:
[email protected]

[Vision_INM @Vision_INM]

We are hosting the 4th International #Choroideremia Research Symposium on 17th May and CHM patient information day on 18th May 2024. All patients welcome to attend. Please contact [email protected] for further information.
@choroideremia @CureCHM #IRDs #Retina

[Vision_INM @Vision_INM]

Reminder for prospective PhD candidates, applications for our Marie Skłodowska-Curie Doctoral Network (2024-2027) named ProgRET closes Friday 15th March.
All information on the program and application process can be found here: https://t.co/MDqUOpfxZ8
@Euroaxess #IRD #Retina

[Vision_INM @Vision_INM]

@Vision_INM supports #RareDiseaseDay
Working daily for and alongside patients affected with rare inherited retinal disorders